Investment Rating - The report does not explicitly state an investment rating for the industry or the specific company being analyzed [1]. Core Insights - The company has optimized its settlement model to enhance competitiveness and attract quality distributors, particularly in response to the accounts receivable situation observed in the medical device sector since the second half of 2023 [17]. - The company has established a distribution network in over 40 countries, focusing on Southeast Asia, Latin America, and countries along the Belt and Road Initiative, with plans to strengthen its international presence by 2025 [18]. - The company anticipates a positive outlook for the medical device market in 2025, driven by favorable policies and an increase in demand due to equipment upgrades [19][20]. Summary by Sections 1. Basic Research Information - The research was conducted on West Mountain Technology on March 7, 2025, with participation from various investment institutions [13]. 2. Detailed Research Institutions - The institutions involved in the research include Bernacheng Fund, Fengyan Fund, Yuefo Fund, Gaoyuan Fund, Hongfeng Investment, and Nuoding Asset Management [14]. 3. Research Institution Proportions - The report does not provide specific data on the proportions of research institutions involved [15]. 4. Main Content Information - The company has implemented a credit policy to manage accounts receivable effectively, focusing on maintaining cash flow amidst extended payment cycles from hospitals [17]. - The company is actively pursuing necessary international certifications and registrations to enhance its overseas business operations [18]. - The report highlights the government's initiatives to promote the medical equipment industry, which are expected to foster innovation and attract businesses to the sector [20].